Survival of Patients with Primary Pedal Melanoma

Journal of Foot and Ankle Surgery

Volumn 42, Issue 4, 2003, Pages 193-198

  Walsh, Susan M ^a,b   Fisher, Susan G ^a   Sage, Ronald A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Greenwich Podiatry Inc   (United States)

Author keywords

Foot; Melanoma; Survival

Indexed keywords

ADULT; AGED; ANKLE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DOCUMENTATION; FEMALE; FOLLOW UP; FOOT; HUMAN; INCIDENCE; KNEE; LEG; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT REFERRAL; SURVIVAL RATE; THIGH; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 0344496885     PISSN: 10672516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1067-2516(03)70028-3     Document Type: Article

References (26)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 44:7-26, 1994.
2. Rigel DS, Friedman RJ, Kopf AW The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 34:839-847, 1996.
3. Rigel DS. Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s. Mayo Clin Proc 72:367-371, 1997.
4. Wender RC. Barriers to effective skin cancer detection. Cancer 75(Suppl 2):691-698, 1995.
5. van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, Briggs J, Cooke RA, Dempster AG, Essex WB. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 47:483-489, 1991.
6. Creagan ET. Malignant melanoma: an emerging and preventable medical catastrophe. Mayo Clin Proc 72:570-574, 1997.
7. Liu T, Soong S. Epidemiology of malignant melanoma. Surg. Clin. North Am. 76:1205-1222, 1996.
8. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 46:5-27, 1996.
9. Sim FH, Nelson TE, Pritchard DJ. Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc 72:565-569, 1997.
10. Kopf AW, Rigel DS, Friedman RJ. The rising incidence and mortality rate of malignant melanoma. J Derm Surg Oncol 8:760-761, 1982.
11. Barnes BC, Seigler HF, Saxby TS, Kocher MS, Harrelson JM. Melanoma of the foot. J Bone Joint Surg 76A:892-898, 1994.
12. Day CL, Sober AJ, Kopf AW, Lew RA, Mihm MC Jr, Golomb FM, Hennessey P, Harris MN, Gumport SL, Raker JW, Malt RA, Cosimi AB, Wood WC, Roses DF, Gorstein F, Fitzpatrick TB, Postel A. A prognostic model for clinical stage I melanoma of the lower extremity - location on foot as independent risk factor for recurrent disease. Surgery 89:599-603, 1981.
13. Fortin PT, Freiberg AA, Rees R, Sondak VK, Johnson TM. Malignant melanoma of the foot and ankle. J Bone Joint Surg 77A:1396-1403, 1995.
14. Garbe C, Buttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzman I, Lechner W, Lippold A, Orfanos CE, Peters A, Rassner G, Stadler R, Stroebel W. Primary cutaneous melanoma - prognostic classification of anatomic location. Cancer 75:2492-2498, 1995.
15. Tseng JF, Tanabe KK, Gadd MA, Cosimi AB, Malt RA, Haluska FG, Mihm MC Jr, Sober AJ, Souba WW. Surgical management of primary cutaneous melanomas of the hands and feet. Ann Surg 225:544-553, 1997.
16. American Joint Commission on Cancer. Manual for Staging of Cancer, 3rd ed, pp 139-144, edited by OH Beahrs and MH Meyers, Lippincott, Philadelphia, 1988.
17. Bennett DR, Wasson D, MacArthur JD, McMillen MA. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg 79:279-284, 1994.
18. Perniciaro C. Dermatopathologic variants of malignant melanoma. Mayo Clin Proc 72:273-279, 1997.
19. Rogers GS, Kopf AW, Rigel DS, Friedman RJ, Levine JL, Levenstein M, Bart RS, Mintzis MM. Effect of anatomical location on prognosis in patients with clinical stage I melanoma. Arch Dermatol 119:644-649, 1983.
20. Urist MM, Balch CM, Soong S, Shaw HM, Milton GW, Maddox WA. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 55:1398-1402, 1985.
21. Rigby HS, Briggs JC. Subungual melanoma: a clinico-pathologic study of 24 cases. Br J Plast Surg 45:275-278, 1992.
22. Bibbo C, Brolin RE, Warren AM, Franklin ID. Current therapy for subungual melanoma. J Foot Ankle Surg 33:184-193, 1994.
23. Clark WH. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. Adv Biol Skin 8:621-647, 1967.
24. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970.
25. Sutherland CM, Mather FJ, Muchmore JH, Carter RD, Reed RJ, Krementz ET. Acral lentiginous melanoma. Am J Surg 166:64-67, 1993.
26. Dwyer PK, Mackie RM, Watt DC, Aitchison TC. Plantar malignant melanoma in a white Caucasian population. Br J Dermatol 128:115-120, 1993.